Fetal and Neonatal Heart Monitor Market: Opportunities Abound for Metabolic Disorder Induced Risks

Rockville, USA,  2019-May-07 — /EPR Network/ —   Fact.MR’s recently published report propounds valuable insights and accurate forecasts on the fetal and neonatal heart monitor market for the period of forecast, 2018 to 2028. Key parameters such as impact of current and future growth determinants & deterrents, expected developments &
regulatory scenario, demand statistics, and raw material procurement & supply are elucidated and analyzed. Influence of these parameters on the fetal and neonatal heart monitor market’s growth has been quantified for deriving a market growth rate estimate.

Global sales of fetal and neonatal heart monitors are likely to surpass 261,000 units in 2018, with rising adoption in the US driving sales. Cardiotocographs remain the highest selling fetal and neonatal heart monitor devices, with global sales equating a valuation of nearly US$ 400 Mn in 2017. Demand continues to remain concentrated in hospitals and neonatal clinics, with the former accounting for a leading share.  Heart-related congenital disorders in the course of pregnancy or the requirement for medical interventions owing to complications such as umbilical cord compression or premature delivery. Women experiencing high risk pregnancy factors such as diabetes, high blood pressure, gestational blood pressure and preeclampsia, who need continuous monitoring to ensure baby’s wellbeing may find fetal and neonatal heart monitor beneficial. In addition, rise in preterm birth has further signified the importance of fetal and neonatal heart rate monitor.

Get Free Sample Report Here:


The number of neonatal intensive care unit (NICU) admission has escalated in the recent years. The NICU integrates trained health care professionals and sophisticated technology aimed at providing specialized care for the tiniest patients. Accordingly, neonatologist along with other health care professionals and parents develop plan of care for high-risk newborns.

There have been several instances of neonatal complications in offspring of pregnant women with heart disease. Obstetric complications and major adverse cardiac events were linked with higher risk of neonatal adverse clinical events (NACE).

Browse Full Report with ToC Here: 


Fetal and Neonatal Heart Monitor Market: Overview

The report offers a robust analysis on the fetal and neonatal heart monitor market with qualitative and quantitative analysis. The report presents a lucid picture of the dynamics of the market, expanding to drivers, opportunities, trends and restraints. These factors become paramount and have great influence in the growth of the fetal and neonatal heart monitor market. Further, the report includes the segmentation of the fetal and neonatal heart monitor market to provide a holistic view.

The report finds that market participants have an opportunity of developing fetal and neonatal heart monitors that can diagnose heart rate patterns occurring due to metabolic disorders, such as fetal metabolic acidemia. The fetal and neonatal heart monitors available in the market are not completely successful in detecting metabolic disorders, with many instances going undetected. Manufacturers who are able to launch highly accurate and advanced fetal and neonatal heart monitors in the market can leverage the opportunities emerging in this segment.

The last section delves into the competitive landscape of the fetal and neonatal heart monitor market with a competition dashboard, developments, benchmarking and deep dive. The section elucidates overview, product portfolio, sales footprint and strategy of leading players in the market.

Fetal and Neonatal Heart Monitor: Novel Modality Developments Offering Framework for Non-Invasive Evaluation

Healthcare professionals recommend intrapartum fetal heart rate (FHR) monitor during labor for proper assessment of fetal wellbeing. Despite high penetration, fetal scalp electrode monitor and external Doppler have been deemed to have significant shortcomings, which in turn has led toward the development of non-invasive modality technologies as possible alternatives. Intrapartum fetal heart rate monitoring using Electronic Uterine Monitoring (EUM) is considered to be a notable development in the field.

Comparative analysis carried out between accuracy of FHR trace via novel EUM, and fetal scalp electrode monitor and external Doppler has shown accuracy of the former to be significant higher. Intrapartum FHR via EUM has been proved to be accurate and valid, offering higher yields in correlations with the internal scalp electrode monitoring and external Doppler. Such novel modality developments are likely to impart greater framework for intrapartum FHR’s non-invasive evaluation.

Have Any Query?? Ask Our Industry Expert


About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us


11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States






Matched content

Editor’s pick

Do NOT follow this link or you will be banned from the site!